Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,826,403
+$239,814 QoQ
Shares Held
7,258
-0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#2,035
of 4,153 holders
Holding Since
Sep 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KILEY JUERGENS WEALTH MANAGEMENT, LLC holds $16,836,624 across 9 Drug Manufacturers - General names. ABBV ranks #3 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,724 | $6,865,537 | |
| 2 | JNJ |
Johnson & Johnson
|
15,679 | $3,981,995 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
7,258 | $1,826,403 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,629 | $1,622,826 | |
| 5 | AMGN |
Amgen Inc
|
3,459 | $1,252,573 | |
| 6 | PFE |
Pfizer Inc
|
20,957 | $504,644 | |
| 7 | AZN |
Astrazeneca PLC
|
1,966 | $372,792 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,561 | $205,184 |
All Filings in ABBV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,826,403 | 7,258 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,586,589 | 7,295 | Shares | Sole | 2026-04-28 | |
| 2023-09-30 | $1,495,071 | 10,030 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $1,532,419 | 11,374 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $2,194,365 | 13,769 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,201,936 | 13,625 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $1,840,824 | 13,716 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $2,099,210 | 13,706 | Shares | Sole | 2022-07-29 | |
| 2021-12-31 | $1,891,538 | 13,970 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $1,301,559 | 12,066 | Shares | Sole | 2021-10-13 | |
| No filing history on record for this holder in this stock. | ||||||